Related Experiment Video
Updated: May 26, 2026
Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer Cells
Sylvie Rodrigues-Ferreira1, Marina Morel, Rosana I Reis
1Inserm, U1016, Institut Cochin, Paris, France.
Abstract:
Recent studies have highlighted the AT1 receptor as a potential therapeutic target in breast cancer, while the role of the AT2 subtype in this disease has remained largely neglected. The present study describes the generation and characterization of a new cellular model of human invasive breast cancer cells (D3H2LN-AT2) stably expressing high levels of Flag-tagged human AT2 receptor (Flag-hAT2). These cells exhibit high-affinity binding sites for AngII, and total binding can be displaced by the AT2-selective antagonist PD123319 but not by the AT1-selective antagonist losartan. Of interest, high levels of expression of luciferase and green fluorescent protein make these cells suitable for bioluminescence and fluorescence studies in vitro and in vivo. We provide here a novel tool to investigate the AT2 receptor functions in breast cancer cells, independently of AT1 receptor activation.
Insights
Researchers developed a new breast cancer cell model to study the AT2 receptor, a target previously overlooked in cancer research. This tool allows independent investigation of AT2 receptor functions in breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- The AT1 receptor is a known therapeutic target in breast cancer.
- The role of the AT2 receptor subtype in breast cancer remains understudied.
- A specific cellular model is needed to investigate AT2 receptor functions independently.
Purpose of the Study:
- To generate and characterize a novel cellular model for studying the AT2 receptor in human invasive breast cancer.
- To enable independent investigation of AT2 receptor functions in breast cancer cells.
Main Methods:
- Generation of a human invasive breast cancer cell line (D3H2LN-AT2) stably expressing Flag-tagged human AT2 receptor (Flag-hAT2).
- Characterization of Angiotensin II (AngII) binding using AT2-selective (PD123319) and AT1-selective (losartan) antagonists.
- Incorporation of luciferase and green fluorescent protein for in vitro and in vivo imaging studies.
Main Results:
- The D3H2LN-AT2 cells express high-affinity binding sites for AngII.
- Binding was displaceable by PD123319 but not by losartan, confirming AT2 receptor specificity.
- The cells are suitable for bioluminescence and fluorescence imaging.
Conclusions:
- A novel cellular model (D3H2LN-AT2) has been developed for studying AT2 receptor functions in breast cancer.
- This model allows for the investigation of AT2 receptor roles independently of AT1 receptor activation.
- This tool facilitates future research into the therapeutic potential of the AT2 receptor in breast cancer.
